Impress employers and recruiters.
Choose from hundreds of resume examples.
Impress employers and recruiters.
Choose from hundreds of resume examples.
Tailor your resume to this Associate Director, Clinical Science role.
Rezi rewrites your resume against Braveheart Bio's job description. Free.
Tailor your resume to this Associate Director, Clinical Science role.
Rezi rewrites your resume against Braveheart Bio's job description. Free.
Don't guess if your resume is good enough.
See how it scores against the Associate Director, Clinical Science posting at Braveheart Bio — free, in seconds.
Don't guess if your resume is good enough.
See how it scores against the Associate Director, Clinical Science posting at Braveheart Bio — free, in seconds.
About the Role
The Associate Director, Clinical Science will be a key scientific contributor responsible for shaping and executing the clinical and translational science strategy for BHB-1893, a novel cardiac myosin inhibitor for hypertrophic cardiomyopathy. This role is critical for preparing the drug for global Phase 3 trials and regulatory submissions, involving protocol design, data review, analysis, and external representation of the science.
Responsibilities
- Partner with Clinical Development leads to shape translational and clinical science strategy for BHB-1893 across oHCM and nHCM.
- Drive scientific input into protocol design and endpoint selection, considering sarcomere biology and disease-specific pharmacodynamic factors.
- Lead clinical and scientific review of clinical data listings, identifying and resolving data anomalies.
- Serve as a key clinical science point of contact with Braveheart's global co-development partner, supporting data review, cleaning, and reconciliation.
- Independently analyze clinical, biomarker, and exploratory endpoint data to generate insights informing program strategy.
- Develop exploratory analyses with Biometrics and Clinical Pharmacology to interrogate complex datasets.
- Author and review clinical study reports, investigator brochures, abstracts/publications, and scientific components of regulatory submissions.
- Represent the science of BHB-1893 with key opinion leaders, at scientific conferences, and in advisory board settings.
Requirements
- PhD or equivalent research doctorate; other advanced degrees (e.g., PharmD, MS with substantial relevant experience) will be considered.
- 6+ years of experience in clinical development and/or translational research.
- Demonstrated experience conducting hands-on review and quality control of clinical data listings.
- Experience collaborating with co-development partners, CROs, or other external organizations on clinical data review, cleaning, and reconciliation, ideally in global Phase 3 trials through database lock.
- Strong independent data analysis skills, including the ability to identify patterns, anomalies, and scientific signals in complex clinical datasets.
- Working knowledge of cardiovascular disease biology, ideally including sarcomere biology and hypertrophic cardiomyopathy.
- Experience authoring or contributing to clinical study protocols, clinical study reports, and regulatory documents (e.g. NDA/MAA submissions).
- Strong interpersonal and communication skills for bridging between scientific and business participants, for negotiating timelines and for effective international collaboration.
- Strong written and verbal communication skills with a collaborative, team-oriented approach.
- Ability to thrive in a fast-paced, dynamic environment and remain comfortable with change and ambiguity.
- Flexible, proactive, and hands-on mindset with a roll-up-your-sleeves, can-do attitude.
Skills
- Programming experience (e.g., R, Python, or SAS) sufficient to analyze clinical datasets
- Track record of developing novel analytic approaches to complex biomarker or clinical trial data
- Experience engaging with KOLs, scientific advisory boards, or presenting at cardiovascular conferences (e.g., ESC, AHA, HFSA)
- Fluency in Mandarin
Location
- Remote
Work Type
- Full-time
Experience Level
- Associate Director
- 6+ years of experience
Education Level
- PhD or equivalent research doctorate
- PharmD
- MS
Salary/Compensations
- $180,000 - $240,000
Benefits
- Annual bonus
- Equity
- Comprehensive benefits offering
About the Company
- Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.
- Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
- Braveheart’s goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity.
- With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area.
Equal Opportunity
- We are an equal opportunity employer.
- We are committed to inclusion and diversity, and we do not discriminate on the basis of race, gender, religion, gender, sexual orientation, age, color, marital status, veteran status, disability status, national origin, or any characteristic protected under applicable law.
- Braveheart participates in the federal E‑Verify program to confirm employment authorization for all new hires.